Joshua A. Parker
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Perverse incentives and ethical challenges for prescribing in English general practice.
Journal: The British journal of general practice : the journal of the Royal College of General Practitioners
Published: March 26, 2026
Repurposing the HMG-CoA Reductase Inhibitor Atorvastatin for SRD5A3-CDG.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
PIKFYVE inhibition mitigates disease in models of diverse forms of ALS.
Journal: Cell
Published: January 25, 2026
Characterization of a C9orf72 Knockout Danio rerio model for ALS and cross-species validation of potential therapeutics screened in Caenorhabditis elegans.
Journal: PloS one
Published: August 22, 2025
Reconciling Subsistence Emissions and Prevention in Environmentally Sustainable Healthcare.
Journal: Journal of bioethical inquiry
Published: May 13, 2025
Suppression of har-1/CHCHD10 phenotypes for ALS-FTD therapy discovery.
Journal: microPublication biology
Published: April 09, 2025
har-1/CHCHD10 mutations induce neurodegeneration and mitochondrial fragmentation in Caenorhabditis elegans.
Journal: microPublication biology
Published: April 09, 2025
Healthcare exceptionalism: should healthcare be treated differently when it comes to reducing greenhouse gas emissions?
Journal: Medicine, health care, and philosophy
Published: January 08, 2025
CHK1 inhibition rescues abnormal glycogen buildup in a Caenorhabditis elegans model for glycogen storage disease III.
Journal: Communications biology
Published: December 09, 2024
Neuronal lipid droplets play a conserved and sex-biased role in maintaining whole-body energy homeostasis.
Journal: Nature metabolism
Published: September 10, 2024
Last Updated: 09/26/2026